1. Home
  2. LEXX vs CKX Comparison

LEXX vs CKX Comparison

Compare LEXX & CKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • CKX
  • Stock Information
  • Founded
  • LEXX 2004
  • CKX 1930
  • Country
  • LEXX Canada
  • CKX United States
  • Employees
  • LEXX N/A
  • CKX N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • CKX Oil & Gas Production
  • Sector
  • LEXX Health Care
  • CKX Energy
  • Exchange
  • LEXX Nasdaq
  • CKX Nasdaq
  • Market Cap
  • LEXX 23.9M
  • CKX 22.6M
  • IPO Year
  • LEXX N/A
  • CKX 1998
  • Fundamental
  • Price
  • LEXX $0.82
  • CKX $10.85
  • Analyst Decision
  • LEXX Strong Buy
  • CKX
  • Analyst Count
  • LEXX 1
  • CKX 0
  • Target Price
  • LEXX $4.00
  • CKX N/A
  • AVG Volume (30 Days)
  • LEXX 1.3M
  • CKX 2.0K
  • Earning Date
  • LEXX 11-25-2025
  • CKX 11-22-2025
  • Dividend Yield
  • LEXX N/A
  • CKX N/A
  • EPS Growth
  • LEXX N/A
  • CKX N/A
  • EPS
  • LEXX N/A
  • CKX 0.18
  • Revenue
  • LEXX $615,923.00
  • CKX $835,960.00
  • Revenue This Year
  • LEXX $46.98
  • CKX N/A
  • Revenue Next Year
  • LEXX $17.26
  • CKX N/A
  • P/E Ratio
  • LEXX N/A
  • CKX $60.77
  • Revenue Growth
  • LEXX 49.85
  • CKX N/A
  • 52 Week Low
  • LEXX $0.77
  • CKX $10.04
  • 52 Week High
  • LEXX $3.28
  • CKX $14.00
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 40.14
  • CKX 38.95
  • Support Level
  • LEXX $0.88
  • CKX $10.96
  • Resistance Level
  • LEXX $1.01
  • CKX $11.40
  • Average True Range (ATR)
  • LEXX 0.12
  • CKX 0.13
  • MACD
  • LEXX -0.06
  • CKX -0.06
  • Stochastic Oscillator
  • LEXX 3.11
  • CKX 16.67

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.

Share on Social Networks: